title: Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
authors.forename: Neil M
authors.initials: NM
authors.lastname: Bressler
authors.forename: Susan B
authors.initials: SB
authors.lastname: Bressler
authors.forename: Laurie A
authors.initials: LA
authors.lastname: Haynes
authors.forename: Yong
authors.initials: Y
authors.lastname: Hao
authors.forename: Peter K
authors.initials: PK
authors.lastname: Kaiser
authors.forename: Joan W
authors.initials: JW
authors.lastname: Miller
authors.forename: Joel
authors.initials: J
authors.lastname: Naor
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Potter
authors.forename: Constantin J
authors.initials: CJ
authors.lastname: Pournaras
authors.forename: Al
authors.initials: A
authors.lastname: Reaves
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Rosenfeld
authors.forename: Ursula
authors.initials: U
authors.lastname: Schmidt-Erfurth
authors.forename: Jason S
authors.initials: JS
authors.lastname: Slakter
authors.forename: Andrew
authors.initials: A
authors.lastname: Strong
authors.forename: Stéphane
authors.initials: S
authors.lastname: Vannier
mesh_terms: D000368:Aged; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy*; D008297:Male; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D013997:Time Factors; D000077362:Verteporfin; D014792:Visual Acuity
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin